NEURODIVERGENCE SCREENING TOOL

Millions of adults across Europe suspect they might have ADHD or Autism Spectrum Disorder — but the path to a formal diagnosis is long, expensive, and emotionally draining. Waiting lists for clinical evaluations stretch from 6 to 12 months. Out-of-pocket costs for a full neuropsychological assessment average around €800. And at the end of all that, many people are simply told what they already suspected.

The real problem isn’t access to diagnosis. It’s the absence of structured, reliable information before you decide to pursue one.

There was no tool that could bridge that gap — until now.

We built Neurodivergence Screening, a comprehensive, evidence-based digital platform designed for adults who want clarity before committing to a clinical process.

The tool covers both ADHD and Autism Spectrum, combining 246 clinically validated questions across 8 diagnostic domains and drawing from 7 peer-reviewed instruments used by psychiatrists and neuropsychologists worldwide: ASRS, CAARS, WURS, AQ, RAADS-R, DSM-5, and ICD-11.

The result is a free, anonymous, and immediate screening — with no registration required — that gives users domain-by-domain scores calibrated against clinical thresholds. Not a self-help quiz. A structured clinical lens, built for people who deserve to make informed decisions.

A Multi-Section Assessment Engine

The screening is structured into two parallel tracks:

1. ADS / ADHD — 4 sections covering inattention, hyperactivity & impulsivity, functional impact, and childhood history (~23 min).

2. Autism Spectrum — 4 sections covering social communication & interaction, restricted & repetitive behaviors, sensory & emotional processing, and developmental history (~25 min).

Each section uses a validated 0–4 response scale, mirroring the instruments clinicians use in formal evaluations.

Instant Results with Clinical Context

Results are delivered immediately after completion — no waiting, no email confirmation. Users receive domain-by-domain scores with visual charts, clear thresholds, and an indication of whether their profile falls in the typical, elevated, or clinically significant range.